The structures of the angucycline antibiotics urdamycin B (5), E (2) and F (9) were established by comparing of their spectra with those of urdamycin A (1). The structures of urdamycins C and D, the largest compounds of this series, are still incomplete (10 and ll). The aglycones urdamycinone C, D and E can be liberated by methanolysis of the corresponding urdamycins. The liberation of urdamycinone B (6) requires an alcohol-free medium, to prevent its rearrangement to the naphthacenequinone 7 or 8. The urdamycins differ from other O-glycoside series in their variety of aglycones.
The structures of the angucycline antibiotics urdamycin B (5), E (2) and F (9) were established by comparing of their spectra with those of urdamycin A (1). The structures of urdamycins C and D, the largest compounds of this series, are still incomplete (10 and ll).
The aglycones urdamycinone C, D and E can be liberated by methanolysis of the corresponding urdamycins. The liberation of urdamycinone B (6) requires an alcohol-free medium, to prevent its rearrangement to the naphthacenequinone 7 or 8. The urdamycins differ from other O-glycoside series in their variety of aglycones.
The colored urdamycins are new angucycline antibiotics produced by Streptomyces fradiae strain Tii 27172). They are biologically active aginst Gram-positive bacteria and stem cells of murine L1210 leukemia. The isolation and characterization of the urdamycins A to F have been described in a previous paper where the group term "angucycline/angucyclinone" has been defined2). In this study we shall give additional structural information for the urdamycins together with the full NMRdata, which for reasons of space were omitted in the first paper. Urdamycins A and E The structure of urdamycin A (1) was deduced by chemical and spectroscopic methods in connection with an X-ray analysis2'3). 1 consists of the aglycone aquayamycin (3) and three 0-glycosidically bonded deoxyhexoses, one /S-D-olivose (sugar B) and two ar-L-rhodinoses (sugars A and C). The 2H NMRdata (Table 1) were given in acetone-c/6, because all urdamycins were soluble in this solvent allowing the spectra to be compared in view of structural differences. The 13C NMRdata for APR. 1987 urdamycin A (Table 2) were evaluated by comparison with aglycone 34) and other glycosides5>6). There was a striking agreement with the data of kerriamycin B7»8) ; thus we assume that both antibiotics are identical although there is given a different configuration for sugar B in the kerriamycin formula.
The minor component urdamycin E (2) is the first sulfur-containing angucycline. In the molecular formula urdamycin E differs from A (1) by CH2S. The sulfur atom is conjugated with the chro- In T>MSO-d6.
After exchange with D2O; d (6). mophoric system as indicated by a significant shift of the UVmaxima2^The NMRdata (Tables 1  and 2) were very similar to those of 1. One of the olefinic protons in positions 5 and 6 existed only as a singlet (3 6.49 ) and a new methyl group (<5H 2.47, 30 14.3) occurred, indicating an >S-methyl group at C-5. Its position was confirmed by a comparison of the NMRdata (5-H/6-H and C-5/C-6 of 1/3 and 2/4, respectively, Tables 1~3) in connection with increment calculations. 6-H is shifted by the neighboring sulfur atom 0.44 ppm up field, C-5 19.2 ppm down field and C-6 10.6 ppm up field. The sign and value of these shifts were as expected9). Treatment with Raney nickel and analysis on TLC plates demonstrated that urdamycin E (2) could be transformed into A (1). Hydrolysis of 2 yielded urdamycinone E (4).
Urdamycin B Urdamycin B (5) is the smallest molecule of the urdamycin complex. The NMRspectra (Tables  1 and 2 ) in comparison with 1 show ring B to be aromatic and subsequently lack of the angularly bonded L-rhodinose (sugar C). Sugars A and B are identical with those of 1.
In the presence of acidic methanol, 5 yielded methyl-^-D-olivosyl-(l ->4)-«:-L-rhodinoside2) and the yellow naphthacenequinone 7. The molecular formula C26H24O7(MW448) of 7 was confirmed by high resolution electron impact mass spectra (HREI-MS) and differed from that of the expected urdamycinone B (6, C25H24O8). The structure of 7 was deduced by analysis of the *H NMRspectrum taking into account a plausible mechanism of the assumed rearrangement. Striking was the lack of the aliphatic protons of ring A and the aromatic AB-protons of ring B in 5 (Table 1) . Instead, four aromatic protons (two broadened IH-singlets at 3 7.13 and 7.44; a 2H-singlet at 3 8.13), one aromatic methyl group (3 2.50) and one aromatic methoxyl group (3 3.88) were observed. The down field shift to two aromatic protons could be explained by their peri-position to the quinone carbonyl groups. Thus, the angular frame of the urdamycin B aglycone has changed to a linear one.
The rearrangement from the expected aglycone 6 to 7 is probably initiated as methanol attacks at C-l (hemiketalization), cleaving the C-l/C-12b bond in a retro Friedel-Crafts reaction. During the cyclization of the open chain methyl ester and the following aromatization to the linear tetracyclic 7, the methoxyl group is retained. This could be confirmed by repeating this reaction with ethanolic sulfuric acid, yielding 8 as main product. The tendency to rearrange from an angular to a linear molecular frame was first shown in the case of aquayamycin (3)10).
Thus, the aglycone urdamycinone B (6) could not be formed in an alcoholic medium but yields of about 50%were possible using tetrahydrofurane as solvent. The spectroscopic data of the aglycone Scheme 2.
were in agreement with the given formula 6. The absolute configuration of the chiral center at C-3 is assumed to be identical with that of the corresponding center of 1 because all urdamycins are derived on the same biosynthetic pathway. Urdamycinone B (6) is a missing link in the series of angucyclinones with an anthraquinone chromophore2). 6 is the first C-9 C-glycoside of tetrangomycin.
Urdamycins C and D Both urdamycin C (red colored) and urdamycin D (blue colored) posses an extended chromophoric system. Comparison of the XHNMR2)and the 13C NMRdata (Table 2 ) with those for urdamycin A (1) and methanolysis of these compounds indicated the sugar pattern and parts of the aglycone, namely the C-glycosidic bonded olivose and the complete ring A, are the same. Urdamycins C and D were synthesized by Streptomyces fradiae in the late phase of the fermentation process, when urdamycin A (1) was already present at a high concentration. Weassume that urdamycins C and D have the same C43-frame as 1 and differ from 1 by additional structural elements, which are attached to the chromophore (partial formulae 10 and ll). This is supported by the observation that the aglycones urdamycinone C and D were liberated by methanolysis of the corresponding urdamycins without any change of the UV maxima. Additionally the 13C NMRspectra (Table 2 and Experimental) showed the lack of the C-12 quinone carbonyl group and the XHNMRdata showed that the two AB-systems Scheme 3. APR. 1987 of 5-H/6-H and 10-H/ll-H in 1 were changed or replaced.
In the fast atom bombardment mass spectrum (FAB-MS)of urdamycinone C the molecule could be seen only as a negative ion at m/z 619. From the NMRdata (Tables 2 and 3 ) it followed that a residue of C8H5and three oxygen atoms must be added to the aglycone urdamycinone A (3) as a hypothetical precursor in the biosynthesis. Thus, the molecular formulae of urdamycinone C (C33H3o012) and urdamycin C (C51H6o019) could be deduced and were in agreement with the elemental analysis. The additional residue is highly unsaturated. Urdamycin D is the only nitrogen containing compoundof the urdamycin complex. The NMR analysis indicated that urdamycinone D was larger than 3 by C10H6NO2.The molecular formula CggHgiNOn for urdamycinone D fitted the FAB-MS(m/z 642, negative ion) best and suggested a molecular formula for urdamycin D (C53H61NO18). As with urdamycin C, the main difference in the XHNMR spectrum in comparison with 1 concerned the aromatic/olefinic hydrogen atoms. The olefinic AB-system was similar to urdamycin C (d 6.16 and 7.06, 7=10 Hz) . Furthermore, an aromatic ABCD-pattern (d 7.20, 7.29, 7.62 and 7.63, 7=7 .5 and 1.5 Hz) was seen instead of the simple ABsystem in 1, and a singlet (5 8.12) and a doublet (d 8.25, 7=2 Hz) could be detected. Further structure elucidation of 10 and ll is under progress.
Urdamycin F The molecular formula of urdamycin F (9) differs from that of 1 by H2O. Comparison of the NMRspectra (Tables 1 and 2 ) of urdamycin F with those of 1 showed that the C-5/C-6 double bond of 1 was hydrated. The position of the hydroxyl group at C-6 and the absolute configuration of this center was deduced by analysis of the XHNMRspectrum: The chemical shift of 5-H2 (<5 2.47 (d) and 2.65 (dd), Table 1 ) precluded close proximity to 7-CO; the proton assignments were confirmed by double resonance experiments. The overall coupling constant of 6-H (3 5.29, J=6 Hz, after exchange with D2O) was in agreement with this H-atom in a quasi-equatorial position. The X-ray analysis of urdamycin A (1) indicated a 4Ci-chair conformation for ring A and a 4aT-half chair conformation for ring B3). Molecular model studies showed that similar conformations of rings A and B are probably in urdamycin F (9) : 4Q (ring A) and 4aT5 (ring B). These energetically favored conformations agreed with the XHNMRdata for ring A ( Table 1 ). The evident deshielding of 4-Hax {Ad 0.6 ppm in comparison with 1) could be explained by its close proximity to 6-OH, which led to the (^-configuration Reactions of Urdamycin B a: 45 mg of5 were dissolved in 50 ml ofMeOHand treated with 10 drops of cone H2SO4at room temperature. After all starting material had reacted (2.5 hours, TLC control, system : CHC13-MeOH, 4 : 1) the solution was poured into ice-water and extracted three times with 50 ml of CHC13.The collected organic layers were evaporated to dryness, dissolved again in MeOHand purified by chromatography on Sephadex LH-20 (column 100 x2.5 cm, MeOH). The main yellow zone contained 12 mg of the 3-(2/,3/,7/-trideoxy-/3-D-arabinohexopyranos-2/-yl)-4-hydroxy-7-methoxy-9-methylnaphthacene-5,12-quinone (7), which was precipitated by pouring a saturated CH2C12solution into /z-pentane:
Rf 0.66 (CHC13 -MeOH, 4:1), 0.57 (CH2C12 -EtOH, 9 : 1); IR (KBr) cm"1 3440, 1670, 1627; UV^max (MeOH and MeOH -HCl) nm (e) 410 (7,300), 305 (31,500), 243 (sh, 29,200) , 225 (42,500); (MeOH -NaOH) 500 (6,400), 293 (31,700), 243 (30,100) 219 (33,700); XH NMR (200 MHz, DMSO-d6, see formula 7 for numbering scheme) 3 1.26 (3H, d, J=6 Hz, 6/-CH8), 1.29 (1H, ddd, /= 12, 12 and 12Hz, 3' -Hax), 2.24 (1H, ddd, /-12, 5 and 2Hz, 3' -He<1), 2.50 (3H, s, 9-CH3), 2.89 (1H, dd, /=9 and 9 Hz, 5' -H), 3.34 (1H, dq, J=9 and 6 Hz, 3.54 (1H, ddd, 9 and 5 Hz, 3.88 (3H, s, c: 20mg 5 was dissolved in 10ml THF and treated with three drops of cone H2SO4. After stirring the solution for 48 hours at room temperature, it was poured into ice-water and extracted three times with 50 ml of CHC13.The evaporated organic layers were chromatographed on silica gel (plates 20x20 cm, CH2C12 -MeOH, 85 : 15) and Sephadex LH-20 (column 50x2.5 cm, MeOH), to yield 8 mg of urdamycinone B (6): IR (KBr) cm"1 3410, 1704, 1673, 1635, 1592; *H NMR, see Table
